Whether you’re considering starting to use cannabis or have already been a user for years, you may want to learn more about Cannabigerol (CBG), the non-psychoactive cannabinoid. It’s made by stopping the conversion of CBGA to THC, and it can be added to everything from gummies to beverages.
Cannabigerol is a Non-Psychoactive Cannabinoid
Unlike other cannabinoids, cannabigerol does not make you high. Instead, it has a lot of health benefits. Some of the major ones include its ability to fight inflammation, anxiety, and pain. In addition, it has been found to have anti-cancer properties.
The benefits of cannabigerol are still being tested. However, early studies are showing promise. For example, tetrahydrocannabivarin has been found to reduce the symptoms of Parkinson’s disease. In addition, CBN has been found to affect mood, energy, and appetite positively. Therefore, CBG is also being studied for its ability to stimulate appetite.
The potential of cannabigerol to reduce the symptoms of chronic inflammatory disease is also exciting. For example, it can reduce nitric oxide production in macrophages and epithelial cells. This reduces oxidative stress, which is believed to cause inflammation significantly.
It’s Produced by Stopping the Conversion of CBGA to THC
Often called the “Grandaddy” of cannabinoids, cannabigerolic acid (CBG) is the acidic precursor of all other cannabinoids. CBG is produced through an enzymatic reaction in the cannabis plant.
It was first identified in a computer model and later confirmed by testing in a mouse embryo fibroblast cell line. CBG is produced in resinous trichomes on the plant’s leaves and flowers. The concentrations of CBG in these areas are much higher than in the fully developed plant.
CBG plays a vital role in the health of the plant. It serves as a substrate for synthesizing D9-tetrahydrocannabinolic acid (THCA). During the growth cycle, the hemp plant breaks down CBGA into CBG and THCA.
CBG is also known to have therapeutic benefits, especially in neurologic disorders. In addition, it has been shown to inhibit the growth of colorectal cancer cells. However, human studies on CBG are sparse.
It May Help IBD
Several studies have looked into the potential benefits of cannabigerol (CBG) in the treatment of inflammatory bowel disease (IBD). CBG has anti-inflammatory properties and may offer several advantages.
CBG reduces the production of nitric oxide and iNOS, two of the pro-inflammatory enzymes in the intestines. It also decreases ROS production by the intestinal epithelial cells. This may help reduce the colon’s inflammation, a common symptom of IBD.
CBG was found to have antioxidant properties in murine intestinal epithelial cells. The study also found that CBG reduced the production of reactive oxygen species (ROS) and nitric oxide in the colon.
CBG also decreased the infiltration of neutrophils into the mucosa. In addition, the edema in the submucosa was reduced. This indicates that CBG is a valuable biomarker for assessing the disease status of IBD patients.
It’s a Niche Market for Hemp Extractors and Resellers
Unlike its stouter cousin, CBG isn’t cheap. The cost of production is such that it’s hard to figure out how much you’re paying. Nevertheless, many savvy entrepreneurs have turned the business into a profitable venture. One such entrepreneur is Precision, which offers end-to-end solutions for the CBG oh-la-la. Its offerings include various high-quality raw materials, a fully integrated and automated CBG grading and testing facility, and a variety of CBG extraction and processing solutions. For more information, visit the company’s website. The company has a solid sales and marketing team that can bring CBG to market in the blink of an eye. The company is also a proud member of the Hemp Industry Association (HIA). As such, the company has a well-rounded membership base of growers, industry experts, and industry leaders.
It can be added to everything from gummies to beverages
Phytocannabinoids are lipids that are responsible for inflammatory and pain responses. These lipids can be powerful anti-inflammatories. They are also capable of inhibiting the pain signals that are sent to the brain. They are also capable of increasing the effectiveness of other cannabinoids.
A 2014 study found CBG to have a protective effect against colon cancer. In addition, the compound reduced the production of nitric oxide and reactive oxygen species in the intestine. The study also noted that CBG was a promising agent for treating Parkinson’s disease.
CBG is the metabolic precursor of all the major cannabinoids. In addition to inhibiting cancer, it is also a potent anti-inflammatory. It also helps preserve neurons, which is essential for neuroprotective purposes. It can also improve motor deficits and stimulate appetite.
